The Medical Research Council (MRC) and LifeArc are
making £16m available to establish a network of Gene Therapy Innovation Hubs, providing access to clinical grade viral vector and translational support for
early phase academic-led gene therapy clinical trials. Funding is available through grants of up to 5-years, to create a diverse network of centrally coordinated and complementary gene therapy facilities in the UK. These hubs aim to amplify the discoveries of academic researchers, harnessing the capabilities, materials and resources that are essential to progressing innovative research towards patient trials.
